Unknown NA INTERVENTIONAL 2-arm NCT02800447

Procarbazine Hydrochloride Capsule (Natulan®) Clinical Trial Protocol

Sponsor: Lee's Pharmaceutical Limited

Updated 7 times since 2017 Last updated: Aug 30, 2018 Started: Jun 30, 2016 Primary completion: Dec 31, 2018 Completion: Dec 31, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Advanced Hodgkin's Lymphoma, this trial is ongoing. The trial is conducted by Lee's Pharmaceutical Limited and has accumulated 7 data snapshots since 2016. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status NA
Sep 2020 — Jan 2021 [monthly]

Unknown Status NA

Status: Active Not Recruiting → Unknown Status
Oct 2018 — Sep 2020 [monthly]

Active Not Recruiting NA

Status: Not Yet Recruiting → Active Not Recruiting

▶ Show 2 earlier versions

Jun 2018 — Oct 2018 [monthly]

Not Yet Recruiting NA
Jan 2017 — Jun 2018 [monthly]

Not Yet Recruiting NA

First recorded

Jun 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Lee's Pharmaceutical Limited

Data source: Lee's Pharmaceutical Limited

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.